Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | HRH1 | P35367 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL7866285 | 0.89 | TSHR (0.36) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL16179185 | 0.83 | TSHR (0.31) | TSHR | |
| SCHEMBL1049312 | 0.81 | DNM1 (0.39) | TDP1TSHR | |
| SCHEMBL28327086 | 0.81 | — | — | |
| SCHEMBL1246327 | 0.80 | TSHR (0.30) | TSHR | |
| SCHEMBL28277436 | 0.79 | DNM1 (0.38) | TDP1TSHR | |
| SCHEMBL6253176 | 0.79 | MAPT (0.43) | TSHR | |
| SCHEMBL2302282 | 0.79 | — | — | |
| SCHEMBL5017564 | 0.78 | — | — | |
| SCHEMBL288304 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020204166-A1 | SOLVENT COMPOSITION AND AEROSOL COMPOSITION FOR CLEANING CONTAINING SAME | 株式会社カネコ化学 | 2020-10-08 | — | — | WO | claimed |
| US-8124185-B2 | Method for manufacturing organic functional layer and organic functional device, and organic functional device manufacturing apparatus | TOPPAN PRINTING CO., LTD. (JP) | 2012-02-28 | — | — | US | claimed |
| US-12227533-B2 | Crystalline forms and methods of producing crystalline forms of a compound | VIKING THERAPEUTICS, INC. (US) | 2025-02-18 | — | — | US | disclosed |
| CN-117567958-A | Anti-fingerprint film containing fluorine-based compound for interior trim part of vehicle and method for manufacturing the same | 现代自动车株式会社 | 2024-02-20 | — | — | CN | disclosed |
| US-20240043459-A1 | CRYSTALLINE FORMS AND METHODS OF PRODUCING CRYSTALLINE FORMS OF A COMPOUND | VIKING THERAPEUTICS, INC. | 2024-02-08 | — | — | US | disclosed |
| EP-4302753-A1 | MICROPARTICLES AND MICROPARTICLE DISPERSION | The University of Tokyo (JP) | 2024-01-10 | — | — | EP | disclosed |
| US-20230404065-A1 | MICROPARTICLES AND MICROPARTICLE DISPERSION | THE UNIVERSITY OF TOKYO (JP) | 2023-12-21 | — | — | US | disclosed |
| CN-116917029-A | Microparticles and microparticle dispersions | 国立大学法人东京大学 | 2023-10-20 | — | — | CN | disclosed |
| WO-2023199768-A1 | FLUOROPOLYETHER GROUP-CONTAINING POLYMER, SURFACE TREATMENT AGENT, AND ARTICLE | 信越化学工業株式会社 | 2023-10-19 | — | — | WO | disclosed |
| CN-113999333-B | Modified fluorosilicone acrylate resin, antifouling and antibacterial coating and preparation method thereof | 上海沪正实业有限公司 | 2023-08-18 | — | — | CN | disclosed |
| CN-116034281-A | Information processing device, information processing method, and program | 特拉沃特科技株式会社 | 2023-04-28 | — | — | CN | disclosed |
| WO-2022186224-A1 | MICROPARTICLES AND MICROPARTICLE DISPERSION | 国立大学法人 東京大学 | 2022-09-09 | — | — | WO | disclosed |
| WO-2022049797-A1 | SOLVENT COMPOSITION AND APPLICATION THEREFOR | 株式会社カネコ化学 | 2022-03-10 | — | — | WO | disclosed |
| CN-111526684-B | Product for preventing adhesive layer from deterioration and manufacturing method thereof | 昆山联滔电子有限公司 | 2021-11-19 | — | — | CN | disclosed |
| WO-2021070534-A1 | PRIMER COMPOSITION FOR SILICONE ADHESIVE | 信越化学工業株式会社 | 2021-04-15 | — | — | WO | disclosed |
| WO-2020116397-A1 | REPLICA MOLD FOR IMPRINTING AND METHOD FOR PRODUCING SAME | 日産化学株式会社 | 2020-06-11 | — | — | WO | disclosed |
| US-8124185-B2 | Method for manufacturing organic functional layer and organic functional device, and organic functional device manufacturing apparatus | TOPPAN PRINTING CO., LTD. (JP) | 2012-02-28 | — | — | US | disclosed |
| US-20090074974-A1 | Method for Manufacturing Organic Functional Layer and Organic Functional Device, and Organic Functional Device Manufacturing Apparatus | TOPPAN PRINTING CO. (JP) | 2009-03-19 | — | — | US | disclosed |
| US-7012160-B2 | Fluorine-containing acetophenone derivative, surface layer material containing the same as photo initiator, article with composite hard coat layer, and method for forming composite hard coat layer | TDK CORPORATION (JP) | 2006-03-14 | — | — | US | disclosed |
| US-20040181087-A1 | Fluorine-containing acetophenone derivative, surface layer material containing the same as photo initiator, article with composite hard coat layer, and method for forming composite hard coat layer | TDK CORPORATION (JP) | 2004-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040181087-A1 | Fluorine-containing acetophenone derivative, surface layer material containing the same as photo initiator, article with composite hard coat layer, and method for forming composite hard coat layer | FLNA, FLNB, RAD51 | CHRM1 3161/4885AKR1A1 585/4885CHRM3 4640/4885 |
| US-20240043459-A1 | CRYSTALLINE FORMS AND METHODS OF PRODUCING CRYSTALLINE FORMS OF A COMPOUND | TBCA, TBCB, TBCD | CHRM1 889/4885AKR1A1 1135/4885CHRM3 1076/4885 |
| US-12227533-B2 | Crystalline forms and methods of producing crystalline forms of a compound | TBCA, TBCB, TBCD | CHRM1 889/4885AKR1A1 1135/4885CHRM3 1076/4885 |
| US-20230404065-A1 | MICROPARTICLES AND MICROPARTICLE DISPERSION | CHMP4B, FGB, PFAS | CHRM1 3802/4885AKR1A1 4679/4885CHRM3 2676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.